AU3249300A - 47 human secreted proteins - Google Patents

47 human secreted proteins

Info

Publication number: AU3249300A
Authority: AU; Australia
Prior art keywords: secreted proteins; human secreted; human; proteins; secreted
Prior art date: 1999-03-12
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU32493/00A

Inventor

George Komatsoulis

Craig A Rosen

Steven M. Ruben

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Human Genome Sciences Inc

Original Assignee

Human Genome Sciences Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-03-12

Filing date

2000-03-09

Publication date

2000-10-04

2000-03-09 Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc

2000-10-04 Publication of AU3249300A publication Critical patent/AU3249300A/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Psychiatry (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Oncology (AREA)
Molecular Biology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Diabetes (AREA)
Transplantation (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Ophthalmology & Optometry (AREA)
Psychology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)

AU32493/00A 1999-03-12 2000-03-09 47 human secreted proteins Abandoned AU3249300A (en)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US12409599P	1999-03-12	1999-03-12
US60124095		1999-03-12
US13859899P	1999-06-11	1999-06-11
US60138598		1999-06-11
US16866599P	1999-12-03	1999-12-03
US60168665		1999-12-03
PCT/US2000/006014 WO2000055199A1 (en)	1999-03-12	2000-03-09	47 human secreted proteins

Publications (1)

Publication Number	Publication Date
AU3249300A true AU3249300A (en)	2000-10-04

Family

ID=27383045

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU32493/00A Abandoned AU3249300A (en)	1999-03-12	2000-03-09	47 human secreted proteins

Country Status (5)

Country	Link
EP (1)	EP1169344A1 (en)
JP (1)	JP2002542767A (en)
AU (1)	AU3249300A (en)
CA (1)	CA2364635A1 (en)
WO (1)	WO2000055199A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6960433B1 (en)	1998-10-19	2005-11-01	Diadexus, Inc.	Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
AU2080001A (en) *	1999-12-07	2001-06-18	University Of Medicine And Dentistry Of New Jersey	Nucleic acid and protein expressed thereby and their involvement in stress
US7033790B2 (en)	2001-04-03	2006-04-25	Curagen Corporation	Proteins and nucleic acids encoding same
AU2012241087B2 (en) *	2003-03-03	2015-07-23	Bracco Suisse Sa	Peptides that specifically bind HGF receptor (cMet) and uses thereof
AU2004217894B2 (en) *	2003-03-03	2010-07-15	Bracco International B.V.	Peptides that specifically bind HGF receptor (cMet) and uses thereof
CA3072634A1 (en) *	2017-10-18	2019-04-25	Sabine Rauth	Human serum albumin variants and uses thereof
CN112661826B (en) *	2020-12-25	2022-03-29	中山大学	Small peptide ERpeptide and application thereof in acute myelogenous leukemia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5654139A (en) *	1994-09-21	1997-08-05	The United States Of America As Represented By The Department Of Health And Human Services	Allelic variation of the serotonin 5HT2c receptor

2000
- 2000-03-09 EP EP00910393A patent/EP1169344A1/en not_active Withdrawn
- 2000-03-09 AU AU32493/00A patent/AU3249300A/en not_active Abandoned
- 2000-03-09 CA CA002364635A patent/CA2364635A1/en not_active Abandoned
- 2000-03-09 JP JP2000605625A patent/JP2002542767A/en not_active Withdrawn
- 2000-03-09 WO PCT/US2000/006014 patent/WO2000055199A1/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP1169344A1 (en)	2002-01-09
WO2000055199A1 (en)	2000-09-21
CA2364635A1 (en)	2000-09-21
JP2002542767A (en)	2002-12-17

Publication	Publication Date	Title
AU1473501A (en)	2001-06-06	21 human secreted proteins
AU1604401A (en)	2001-05-30	18 human secreted proteins
AU1438001A (en)	2001-05-14	27 human secreted proteins
AU1448701A (en)	2001-06-06	15 human secreted proteins
AU1334101A (en)	2001-05-14	19 human secreted proteins
AU3769700A (en)	2000-10-16	45 human secreted proteins
AU2757500A (en)	2000-08-29	33 human secreted proteins
AU3517000A (en)	2000-10-04	50 human secreted proteins
AU1918601A (en)	2001-05-30	23 human secreted proteins
AU1916101A (en)	2001-06-06	19 human secreted proteins
AU3628600A (en)	2000-10-09	46 human secreted proteins
AU3765500A (en)	2000-10-16	50 human secreted proteins
AU1342501A (en)	2001-05-14	32 human secreted proteins
AU3396600A (en)	2000-10-04	49 human secreted proteins
AU3249300A (en)	2000-10-04	47 human secreted proteins
AU3208700A (en)	2000-08-07	33 human secreted proteins
AU1449001A (en)	2001-06-06	28 human secreted proteins
AU1472801A (en)	2001-06-06	24 human secreted proteins
AU3766800A (en)	2000-10-16	48 human secreted proteins
AU3767300A (en)	2000-10-16	47 human secreted proteins
AU3628700A (en)	2000-10-09	49 human secreted proteins
AU3871300A (en)	2000-10-04	50 human secreted proteins
AU3730500A (en)	2000-10-09	50 human secreted proteins
AU1655701A (en)	2001-06-06	15 human secreted proteins
AU3747000A (en)	2000-10-09	49 human secreted proteins

Legal Events

Date	Code	Title	Description
2002-02-28	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase